Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

Discover the comprehensive insights of "Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology," authored by Mohammad Resa Nowrousian and published by Springer Verlag GmbH in 2016. This indispensable resource spans 866 pages and is designed for healthcare professionals navigating the complexities of anemia, a common yet challenging complication in cancer patients. The second edition updates and enriches the content with new chapters covering a wider range of topics. Esteemed international experts delve into both the scientific and clinical dimensions of anemia in oncology, offering evidence-based diagnostic and therapeutic recommendations. Learn when and how to effectively utilize rhEPO to enhance patient care and outcomes. This book is a must-have for anyone involved in oncology and hematology, ensuring that you stay informed on best practices in managing anemia related to cancer treatment.